All stock lists
Mustang Bio, Inc. (NASDAQ:MBIO)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.36-0.01 (-2.70%)
Insider Score
––Not scored
MBIO Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
MBIO Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 41.00 K |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -41.00 K |
| SG&A Expense | 946.00 K | 880.00 K | 987.00 K | 957.00 K | 787.00 K | 1.22 M |
| R&D Expense | 224.00 K | 178.00 K | -317.00 K | 333.00 K | 98.00 K | 964.00 K |
| Operating Expenses | 1.17 M | 1.06 M | 670.00 K | 624.00 K | 885.00 K | 212.00 K |
| Operating Income | -1.17 M | -1.06 M | -670.00 K | -624.00 K | -885.00 K | -253.00 K |
| Pretax Income | -1.07 M | -955.00 K | -538.00 K | -468.00 K | -762.00 K | -153.00 K |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -1.07 M | -955.00 K | -538.00 K | -468.00 K | -762.00 K | -153.00 K |
| EPS (Basic) | -0.16 | -0.14 | -0.07 | -0.07 | -0.13 | -0.05 |
| EPS (Diluted) | -0.16 | -0.14 | -0.07 | -0.07 | -0.13 | -0.05 |
| Shares Outstanding | 6.73 M | 6.73 M | 7.30 M | 6.24 M | 5.98 M | 5.72 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.